New hope for people with breathing condition, COPD, as NICE approves innovative treatment
Breakthrough therapy reduces flare-ups by almost a third and could ease pressure on NHS hospitals.
News, blogs and podcasts
Latest articles
Thousands could benefit from new take-at-home treatment for advanced prostate cancer
NICE recommends life-extending daily pill which offers hope for people who cannot take standard treatment.
Online help programme recommended for people with eating disorders
An online therapy programme can be used to help people aged 16 and over with eating disorders whilst they wait for specialist NHS treatment, an independent NICE has said.
Thousands living with lupus offered hope from twice-yearly infusion
NICE approves breakthrough combination treatment that restores normal kidney function in almost half of patients with lupus nephritis.
Latest in-depth
NICE in 2025: Helping to get the best care to people fast
As Sam Roberts prepared to hand over the baton as chief executive, she reflected on her time at NICE and looked to the next chapter for the organisation. She also reflected on our 2025 highlights and achievements in delivering our transformation plan and our commitments in the 10 Year Plan.
10 Year Plan for the NHS
NICE is poised to deliver key commitments in the government’s 10 Year Plan for health and care. We’re delighted by the plan’s endorsement of our role in delivering faster, and fairer access to the best innovations. It will strengthen our position in the system, guided by our core purpose.
Latest blogs
NICE’s prioritisation process explained – what healthtech developers need to know
Understand why we're prioritising key topic areas for evaluation and what it means for innovators
5 tips to help get your healthtech product to market, fast
Our associate director of NICE Advice outlines his top tips for healthtech companies, helping them chart a clear path from innovation to NHS adoption.
Latest podcasts
How NICE is helping to deliver the government's 10 Year Plan for healthcare
Treating type 2 diabetes with SGLT-2 inhibitors
